Wells, L.; O’Hara, N.; Frye, R.E.; Hullavard, N.; Smith, E. J. Pers. Med. 2024, 14, 166.
Frye RE, McCarty PJ, Werner BA, Scheck AC, Collins HL, Adelman SJ, Rossignol DA, Quadros EV. J Pers Med. 1 Jan 2024.
Posted by: Potomac Psychiatry
Posted on: April 13, 2023
Read Now
Title: Levoleucovorin Treatment for Autism
Date: December 2022
Location: Synchrony 2022 – The BRAIN Foundation
Presented by: Dr. Richard Frye, MD PhD
Frye RE, Lane A, Worner A, Werner BA, McCarty PJ, Scheck AC, Collins HL, Adelman SJ, Quadros EV, Rossignol DA. J Pers Med. 2022 Dec 8;12(12):2033. doi: 10.3390/jpm12122033. PMID: 36556254; PMCID: PMC9786140.
Title: Cerebral Folate Metabolism Abnormalities in Neurodevelopmental Disorders
Date: July 1, 2022
Location: SEECA
Presented by: Dr. Richard Frye, MD PhD
Rossignol DA, Frye RE. J Pers Med. 2021 Nov 3;11(11):1141. doi: 10.3390/jpm11111141. Erratum in: J Pers Med. 2022 Apr 29;12(5): PMID: 34834493; PMCID: PMC8622150.
Posted by: KPHO/KTVK Nightly News
Posted on: September 17, 2021
Watch Video
Title: Interview/Live Chat
Date: May 14, 2021
Location: Autism Research Coalition Online
Featuring: Dr. Richard Frye, MD PhD
Frye RE, Rossignol DA, Scahill L, McDougle CJ, Huberman H, Quadros EV. Semin Pediatr Neurol. 2020 Oct;35:100835. doi: 10.1016/j.spen.2020.100835. Epub 2020 Jun 25. PMID: 32892962; PMCID: PMC7477301.
Title: Autism & Folate
Date: April 25, 2019
Location: Autism Hope Alliance
Presented by: Dr. Richard Frye, MD PhD
Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S, Jill James S, Sequeira JM, Quadros EV. Mol Psychiatry. 2018; 23(2):247-256.
Frye RE, Slattery JC, Quadros EV. Biomark Med. 2017 Aug;11(8):687-699. doi: 10.2217/bmm-2017-0109. Epub 2017 Aug 3. PMID: 28770615.
Title: Folate Metabolism, Mitochondrial Disease and ASD
Date: March 1, 2017
Location: Autism Research Institute
Presented by: Dr. Richard Frye, MD PhD
Frye RE, Wynne R, Rose S, Slattery J, Delhey L, Tippett M, Kahler SG, Bennuri SC, Melnyk S, Sequeira JM, Quadros EV. J Neuroendocrinol. 2017; 29(3).
By Nick Zagorski
Posted: December 2, 2016
Read Article
Posted by: KUAF
Posted on: October 26, 2016
Open Podcast
By: Autism Speaks
Posted: October 18, 2016
Read Article
By: Ryan Maass
Posted: October 18, 2016
Read Article
By Springer
Posted: October 18, 2016
Read Article
Peer Reviewed Publication
Journal of Molecular Psychiatry
Published October 18, 2016
Read Article
By: Carrie Arnold and Spectrum
Posted: September 30, 2016
Read Article
Posted by: Autism Research Connection
Posted on: March 15, 2016
Open Podcast
Read Transcripts
Frye RE, Delhey L, Slattery J, Tippett M, Wynne R, Rose S, Kahler SG, Bennuri SC, Melnyk S, Sequeira JM, Quadros E. Front Neurosci. 2016; 10:80.
By: N of One Autism Research Foundation
2016
Read Article
By: Becky Gillette
Posted: November 11, 2015
Read Article
Posted by: Mito Action
Posted on: June 1, 2012
Open Podcast
Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Mol Psychiatry. 2013; 18(3):369-81.
This test measures two proteins in the blood called autoantibodies whichinterfere with the ability of the vitamin folate to be used by the brain and other parts of the body.The two autoantibodies are called ‘blocking’ and ‘blinding’ and then each may be ‘negative’, ‘low’, ‘medium’ or ‘high.’
